| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,417 |
1,352 |
$78K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,116 |
1,094 |
$55K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
505 |
498 |
$52K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
342 |
335 |
$28K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
339 |
334 |
$10K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
117 |
117 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
214 |
211 |
$5K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
282 |
282 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
190 |
190 |
$2K |
| 87634 |
|
31 |
31 |
$2K |
| 90461 |
|
26 |
26 |
$1K |